Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing ...

Background: Dedifferentiated liposarcoma (DDLPS) is a rare mesenchymal cancer originating from the adipose tissue, with poor survival rates for most patients, highlighting the critical need for novel ...

The FDA has granted a breakthrough therapy designation (BTD) to letetresgene autoleucel (lete-cel) for the treatment of patients with unresectable or metastatic myxoid/round cell liposarcoma (MRCLS).

ASTX-295 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Well Differentiated Liposarcoma. According to GlobalData, Phase II drugs for Well Differentiated ...